DeSantis continues three-year fight to cut prescription costs - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Health/Employee Benefits News
Newswires RSS Get our newsletter
Order Prints
January 13, 2023 Newswires
Share
Share
Post
Email

DeSantis continues three-year fight to cut prescription costs

Gainesville Sun, The (FL)

TALLAHASSEE – Continuing a fight over drug prices, Gov. Ron DeSantis said Thursday that he will push legislation this spring aimed at limiting the influence of large pharmacy benefit managers that he accused of driving up costs.

DeSantis went to The Villages, the sprawling Central Florida retirement haven, to announce the outlines of a plan intended to restrict PBM practices that he said make customers buy costlier drugs, force them into mail-order pharmacies to have prescriptions filled, and hurt local pharmacies.

"This package of reforms is a great step in the right direction," DeSantis said.

Florida lawmakers begin the 2023 session in March. The proposal touted Thursday is expected to be finalized in coming weeks and taken up during the session.

As leader of the nation's biggest retiree state, DeSantis has been battling the industry and federal government over pharmacy costs for more than three years. He was an early backer of efforts by former President Donald Trump's administration to allow for the importation of some prescription drugs from Canada, seen as potentially lowering costs.

Under President Biden, the effort has not advanced far, with federal health regulators citing that more research was needed to assure drug safety.

Florida last August sued the U.S. Department of Health and Human Services and the Food and Drug Administration, accusing the agencies of stalling the state's plan to import lower-cost prescription drugs from Canada.

The state primarily planned to use the Canadian drugs to lower Florida taxpayer costs in Medicaid programs, with other prescription drug customers helped primarily if such actions prompted more across-the-board savings.

While the state's lawsuit continues, the Biden administration's Inflation Reduction Act last year was intended to let the federal government negotiate to lower drug prices for seniors in Medicare, likely reducing the need for less expensive imports from Canada.

DeSantis said Thursday that the "FDA has stonewalled us for two years on this issue." The Republican governor also cited his own skepticism about COVID-19 vaccinations promoted by federal officials as part of what he indicated was some form of hypocrisy.

"You know the FDA isn't as concerned about safety when they're authorizing mRNA shots for 6-month-old babies," DeSantis said, drawing cheers from dozens of seniors attending the event.

He said at The Villages that he expected the Republican-controlled Legislature to bolster existing prohibitions against vaccine requirements and mask-wearing in public places.

DeSantis was joined at the appearance by Florida Surgeon General Joseph Ladapo, who last week was criticized by colleagues at the University of Florida Medical School for issuing Health Department guidance that warned younger men against getting COVID-19 vaccinations because of possible health risks.

A UF task force concluded the research Ladapo relied on was of "highly questionable merit."

But Ladapo endorsed DeSantis' drug-pricing approach, saying that the "health care industry is just a big tangled mess."

John Kennedy is a reporter in the USA TODAY Network's Florida Capital Bureau. He can be reached at jkennedy2@gannett.com, or on Twitter at @JKennedyReport

Older

They hired him to settle their Hurricane Ida claims. He kept their payouts, police say.

Newer

Wrightsville Beach prepares to weather another hurricane season as it waits for sand

Advisor News

  • CT governor’s candidates claims: What’s true, and what’s misleading
  • Retaining clients by giving them a memorable experience
  • Addressing the longevity paradox
  • Employers shift focus from retirement access to financial outcomes
  • Helping widowed clients navigate their new financial reality
More Advisor News

Annuity News

  • Foresters Financial appoints Tom Ross as chief distribution officer for U.S. annuity sales
  • Symetra and TIAA Announce Launch of Mariner Re
  • Jackson Launches Suite of Fixed Index Annuities Focused on Accumulation
  • Farm Bureau P&C insurers post first underwriting gain since 2021
  • Legacy Marketing, Malibu Life launch two fixed indexed annuities
More Annuity News

Health/Employee Benefits News

  • Study: Colorado's Medicaid covers more services than private insurance
  • Healthcare affordability and access could shape Congress’ post-midterm priorities
  • The percentage of people without health insurance is growing
  • Shopping for ACA plan this year? Here’s what you need to know
  • 10 things to know about open enrollment for 2027
More Health/Employee Benefits News

Life Insurance News

  • Northwestern Mutual announces record $10B dividend payout
  • South Carolina, Atlantic Coast mediation fails to resolve reserving dispute
  • Life insurer ordered to stop selling policies in Virginia
  • Symetra and TIAA Announce Launch of Mariner Re
  • Jackson Launches Suite of Fixed Index Annuities Focused on Accumulation
Sponsor
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • Benefits Studio Launches to Fill the Missing Middle of Benefits Navigation at $49/mo
  • Lauren Sinnott Named to Ragan’s Top Women in Marketing Awards, Class of 2026 
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.